Patents by Inventor Terhi Karpanen

Terhi Karpanen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED VEGF-A WITH IMPROVED ANGIOGENIC PROPERTIES
    Publication number: 20120071406
    Abstract: The present invention is directed to methods and compositions for making and using chimeric polypeptides that comprise a VEGFR-2 ligand. The chimeric molecules of the present invention retain VEGFR-2 binding activity and an enhanced angiogenic activity as compared to native VEGF-A.
    Type: Application
    Filed: August 19, 2011
    Publication date: March 22, 2012
    Applicant: VEGENICS PTY LIMITED
    Inventors: KARI ALITALO, Tuomas Tammela, Salla Keskitalo, Katri Pajusola, Markku M. Jeltsch, Seppo Yla-Herttuala, Terhi Karpanen, Ulf Eriksson, Marko J. T. Uutela
  • Modified VEGF-A with improved angiogenic properties
    Patent number: 8025886
    Abstract: The present invention is directed to methods and compositions for making and using chimeric polypeptides that comprise a VEGFR-2 ligand. The chimeric molecules of the present invention retain VEGFR-2 binding activity and an enhanced angiogenic activity as compared to native VEGF-A.
    Type: Grant
    Filed: August 15, 2006
    Date of Patent: September 27, 2011
    Assignee: Vegenics Pty Ltd
    Inventors: Kari Alitalo, Tuomas Tammela, Salla Keskitalo, Katri Pajusola, Markku M. Jeltsch, Seppo Yla-Herttuala, Terhi Karpanen, Ulf Eriksson, Marko J. T. Uutela
  • Modified VEGF-A with improved angiogenic properties
    Publication number: 20070142282
    Abstract: The present invention is directed to methods and compositions for making and using chimeric polypeptides that comprise a VEGFR-2 ligand. The chimeric molecules of the present invention retain VEGFR-2 binding activity and an enhanced angiogenic activity as compared to native VEGF-A.
    Type: Application
    Filed: August 15, 2006
    Publication date: June 21, 2007
    Applicants: LUDWIG INSTITUTE FOR CANCER RESEARCH, LICENTIA LTD.
    Inventors: Kari Alitalo, Tuomas Tammela, Salla Keskitalo, Katri Pajusola, Markku Jeltsch, Seppo Yla-Herttuala, Terhi Karpanen, Ulf Eriksson, Marko Uutela
  • Compositions and methods for treatment of lymphatic and venous vessel arterialization
    Publication number: 20060025338
    Abstract: The present invention is directed to methods and compositions that may be used in disrupting the association of smooth muscle cells with lymphatic endothelial cells and in correcting the valvular dysfunction in veins and lymphatic vessels. Such compositions are useful for therapeutic and prophylactic treatment of impaired lymphatic and venous function, particularly for the treatment of lymphedema distichiasis or chronic venous insufficiency.
    Type: Application
    Filed: March 8, 2005
    Publication date: February 2, 2006
    Applicants: LUDWIG INSTITUTE FOR CANCER RESEARCH, LICENTIA, LTD.
    Inventors: Kari Alitalo, Tatiana Petrova, Terhi Karpanen, Camilla Norrmen